•Over 35 years of experience in health care •Chief Executive Officer of a 13-site state operation for a private ambulatory health care agency •Leader in a variety of not-for-profit and investor-owned health care delivery organizations •Over 15 years of experience at The Joint Commission and 18 years at Joint Commission International Thomas Kozlowski joined Joint Commission Resources in 2001 and subsequently consulted with both domestic and international health care organizations in the areas of accreditation readiness and standards compliance. Dr. Kozlowski's consulting expertise in hospital, ambulatory care, behavioral health care, and long term care settings includes operational assessment; patient safety assessment; environment of care; executive leadership and governing bodies; performance improvement; implementation strategies for rapid response teams; electronic health record assessment; and incorporating tracer methodology and the periodic performance review as management tools. Dr. Kozlowski has consulted internationally in Asia Pacific Region, Europe, the Middle East and the Americas. EXPERIENCE WITH HEALTH CARE FACILITIES •Associate Director of Operations for the Accreditation Division, The Joint Commission •Associate Director for the Department of Standards, The Joint Commission •Administrator in freestanding hospitals, inpatient and outpatient mental health and chemical dependency programs, residential programs, and foster care organizations •Chief Executive Officer for ambulatory health care statewide system •Interim Director of Accreditation/Regulation and Quality for an academic teaching acute care hospital and multi-site ambulatory system •Corporate Director of Quality Improvement and Research for a multi-state health maintenance organization

Healthcare Administration

Dr. Sharma serves as Consultant OncoPathologist at SRL Diagnostics. He has in the past served as Consultant Onco-pathologist, molecular pathologist and Head of Quality assurance at CORE Diagnostics, Gurgaon. He has done MBBS from Manipal with distinction in 5 subjects, an aggregate percentage of 73% with highest marks in Pathology. He has trained in oncopathology at HCG Cancer Hospital, Bangalore from where he completed his primary DNB. He was previously working as Block Chief Medical Officer with Govt. of Rajasthan. He is an expert orator and has delivered talks as Guest speaker at numerous forums nationally like Indian Cancer Congress, YROC, Oncocon, BCFICON etc and internationally at numerous conferences like PathSoc (UK), Nigerian Medical Association, Bangladesh Association of haematologists etc. He has had the distinction of being the faculty, mentor for the First national Hands on IHC workshop of the country, held at JNMC, Belgavi at the 36th National Pathology CME. He recently presented his study on 156 cases of Diffuse large B cell lymphomas with double and triple hit at International Lymphoma and Myeloma congress, New York. He has numerous publications in national and international journals like South Africal Journal of Gynecological oncology, RCPATH and Archives of Pathology including the first reported case of cellular ovarian fibroma from India and presentations at conferences like College of American Pathologists (CAP, Chicago), International Society of Paediatric Oncology (SIOP) (Kyoto, Japan) and Myanmar Society of Hematology. He has had the distinction of reporting nearly 500 cases of lymphomas annually. He is a member of numerous organisations like Indian Association of Pathologists and The Cytometry Society of India. His main areas of work include Oncopathology, IHC, Lymphomas, Flowcytometry and Molecular assays in cancer.

Oncopathologist

Professor Vinay Sharma is Head, Department of Radiation Oncology at Charlotte Maxeke Johannesburg Academic Hospital, University of Witwatersrand. He has published over 150 papers in in national and international peer reviewed journals as well as book chapters. He has delivered over 100 lectures His main research interest is in breast cancers as well as gynecological malignancies.

Radiation oncology

Dr. Ko obtained his PhD degree in Pharmacology at the University of Hong Kong Medical School after completion of his undergraduate training at the University of Toronto, Canada with double specialists in Toxicology and Nutritional Sciences. He has been actively involved in many research projects, published over 100 papers in reputed journals and serving as an editorial board member of various journals including those of the Nature Publishing Group. He is currently member of the American Association for Cancer Research (AACR), European Association for Cancer Research (EACR) and International Union of Basic and Clinical Pharmacology (IUPHAR).

Clinical Pharmacology

Dr. Daniel Gandia is a Clinical Oncologist that has been and is involved in Cancer Medicine for many years. He is involved in the guidance of Clinical Oncology Trials in an important worldwide American CRO. He has published several papers in important Journals and he also teaches Cellular and Molecular Biology at the School of Medicine in Buenos Aires. Mathematical Oncology has become in last years a quiz for him. Email: [email protected]

Clinical Oncology

Prissadee Thanaphongdecha has done Doctoral of philosophy in Pathobiology and Bachelor degree in Medical science. He is currently working in Faculty of medicine, Khonkaen university, Thailand

Pathobiology

Dr. Paulus S. Wang was a professor of the Department of Physiology, National Yang-Ming University (NYMU). Now he is a Chair-Professor and also the Director in the Medical Center of Aging Research, China Medical University Hospital (CMUH). During his academic life in NYMU and CMUH. Dr. Wang creates the concept that the lactate caused by exercise stimulates the productions of progesterone in females and testosterone in males and that both digitalis and bufalin inhibit the proliferation of different human prostate cancer cells. He established the Master and Ph. D. programs for the Institute of Physiology in NYMU. He is the Founder of both the Society of Adaptive Science in Taiwan (SAST) and the Taiwan Society of Endocrinology and Metabolism (TSEM).

Physiology

Salam Azad is a freelance Writer and President of Soheli Mirza Cancer Foundation. Azad had raised the issue of Islamist fundamentalism. Madrasa (Islamic School) education and the practice of issuing fatwa. A fearless writer, continues to crusade against injustice committed by Bangladesh society and government, particularly the failure to protect the rights of the minorities.

Cancer studies

Baljeet Singh Talwar is a graduate from Moscow Power Engineering Institute (Technical University) with a passion of Microwave Technology and has a vast experience in International Business in healthcare(Pharmaceutical & Information Technology).He has the experience of handling scientific and technical development, management of research, interaction with medical consultants of the project. Organization of R & D, production of medical equipment, international scientific cooperation & publications.

Advanced Preventive Medicine.

MS. SUCHI is an experienced International Pre School Principal/Manager who picked up Laughter exercises from many coaches around the world. She then designed ‘Laughter Therapy' which is being used in many places such as hospitals and Senior Activity Centres. She provides individual and group therapy in educational and home settings.

Neurology/Psychiatry /Public Health

Dariusz Borys is an Associate Professor of Pathology and Orthopedic Surgery, Head of Orthopedic and Pediatric Pathology and Director of Digital Pathology at Loyola University Chicago. He has received his Doctor of Medicine from the University of Wroclaw, Poland in 1994 and completed a residency program in anatomic pathology at County General Hospital in Wroclaw, Poland in 1995. He completed his postdoctoral research at the University of Arizona, Tucson, Arizona in 1998. He continued on with and completed residency training in both anatomic pathology and clinical pathology at University of Illinois at Chicago in 2001. He has received a Pediatric Pathology Fellowship at New York University, New York, New York in 2005 and followed that with an Orthopedic Pathology Fellowship at NYU Hospital for Joint Diseases, New York, New York in 2006. After completing his fellowships, he becomes faculty member in the rank of assistant professor at University of California and then he finally moved to Loyola University Chicago in 2013. At LUMC he is appointed as an Associate Professor of Pathology and Orthopedic Surgery and is serving as the head of orthopedic and pediatric pathology and director of digital pathology. Currently his research focuses on the molecular markers in diagnostic, prognostic and targeted therapy in osteosarcoma.

Pathology and Orthopedic Surgery, Head of Orthopedic and Pediatric Pathology

Severyanova L A has Performed research at Kursk State Medical University and received her PhD and later Russian “Doctor of Medicine” at the Pavlov Institute of Physiology of the Russian Academy of Sciences. She has been the Head of the Department of Pathophysiology, Dean of the International Faculty, Professor of Pathophysiology, Honored Worker of Higher School. Her Scientific interest is the integration of nervous, endocrine and immune mechanisms in the systemic reactions of the body. She has published more than 50 articles in reputed journals and three monographs.

Pathophysiology

Anshoo Agarwal is currently working as Professor and In-charge of Pathology Department (female campus), Northern Border University, Kingdom of Saudi Arabia. She has received her Degree from King George’s Medical College. She had been Discipline Coordinator (Pathology Dept.) in University Technology MARA, Malaysia. She is a member of many associations like Indian Association of Pathology and Microbiology, International Academy Pathology, Indian Society of Hematology and Transfusion Medicine, Emirates Medical Association Pathology Society, International Economics Development Research Center etc. She has more than 100 publications. She is Editorial Member of three journals and is reviewer in many journals. She had organized many national and international CME’s, Workshops and Conferences.

Hematology and Transfusion Medicine

Dr. Alvaro Macieira-Coelho is a Research Director at the French National Institute of Health. He received an MD from the University of Lisbon, Portugal, and a PhD from the University of Uppsala Sweden. He made an internship at the University Hospital in Lisbon and was a research associate at the Wistar Institute in Philadelphia (USA) and at the Department of Cell Biology of the University of Uppsala (Sweden). He became Head of the Department of Cell Pathology at the Cancer Institute in Villejuif (France) and was a visiting Professor at the University of Linkoping (Sweden). He published 150 papers in professional Journals and 9 books on cancer and aging. He received the following awards: Fritz Verzar Prize (University of Vienna, Austria), “Seeds of Science”, Career Prize (Lisbon, Portugal), Dr. Honoris Causa (University of Linkoping, Sweden), Johananof International Visiting Professor (Institute Mario Negri, Milano, Italy).

Cancer Research, Cell Biology, Cancer and Aging, Molecular Biology

Liane Deligdisch graduated Medical School in Bucharest, Romania. Following positions were: Gynecologist and General Physician in Romania until 1963, Pathologist at the Ichilov Hospital, Tel Aviv Medical School, Israel 1963 to 1975, Visiting Professor Magee Women Hospital in Pittsburgh, Pa.; 1975-6 Boston Free Hospital for Women, Harvard Medical School ; 1976 to present The Mount Sinai School of Medicine, full Professor of Pathology and Obstetrics-Gynecology and Attending since 1986. Founded the division of Gynecologic Pathology and directed the course of Gynecologic Pathology at the Medical School, Authored 143 peer reviewed articles , 7 textbooks on Gynecologic Pathology.

Gynecology, Obstetrics-Gynecology, Gynecologic Pathology

Dr. Sherry Bradford attended undergraduate school at SUNY at Buffalo and was awarded a full tuition scholarship to pursue her PhD graduate degree (Biochemistry) from the University of Buffalo/ Roswell Park Cancer Institute Division of SUNY at Buffalo School of Medical and Biomedical Sciences. During her clinical laboratory vocation, she was solicited by the Chief of Surgery at Millard Fillmore Hospital, Buffalo, NY, to direct the Surgical Research laboratory. There she successfully led the research on the use of human micro vascular umbilical cord endothelium for lining stents. It was while Sherry was at Millard Fillmore Hospital, that she was awarded the “1st Place - Award for Excellence in Research” from the American Federation for Clinical Research In 1997, Dr. Bradford was approached by the Department of Pharmacokinetics, at Millard Fillmore Hospital, to lead their newly formed Pharmacokinetics Oncology Department. As the Principal Investigator, she was charged with the responsibility to develop an in vitro chemo sensitivity test on tumor cells using the flow cytometer. In 2008, Dr Bradford and colleagues form AccuTheranostics and the idea on Oncology Personalized Medicine based on the specific patient’s own biochemical and genetic profile to administer Personalized treatment regimens.Currently, Dr. Bradford sits on the EDITORIAL BOARD of the International Journal of Medical and Health Sciences Research; commence on July 20 2014; and on the EDITORIAL BOARD of Insights in Cancer Research, and has authored and co-authored a number of scientific peer-reviewed manuscripts.She is also a member of many professional organizations including (but not limited to): International Metabolic Cancer Group, AACR, ASCO, and GLIFCA.

Research interest includes human microvascular umbilical cord endothelium and in Pharmacokinetics Oncology

Oliver Micke has completed his PhD at the age of 25 years from Muenster University Hospital in 2006. He is head of the Head of the department for radiotherapy and radiation oncology at the Franziskus Hospital Bielefeld since 2006. In addition he is the medical director of Franziskus Hospital Bielefeld, a premier teaching hospital of the Medical University of Hanover (MHH). He has published more than 200 papers in reputed national and international journals and has been serving as reviewer as well as an editorial board member of repute.

Radiotherapy, Radiation Oncology

ORONZO BRUNETTI graduated cum laude in 2008 from the University of Bari School of Medicine, Bari, Italy. Since graduation, he has become involved in studies on translational research in solid tumors. Since 2014, he is a member of AIOM (the Italian Association of Medical Oncology). Since 2015, he is a member of the Italian Group for Diagnosis and Treatment of Biliary Cancer (GICO). From 2016 he has been involved in the elaboration of guidelines of exocrine pancreatic carcinoma for the AIOM.

Identification of prognostic/predictive biomarkers in pancreatic, biliary, and hepatocellular cancer.

Xu Dong Zhang received his PhD degree from the University of Sydney in 2001 and has been working on translational melanoma research since then. His major research interest is in regulation of programmed cell death and survival signal pathways in melanoma cells. He is a Professor and ta co-director of the Priority Research Center for Cancer of the University of Newcastle. He is also the Deputy Director of the Cancer Research Program of the Hunter Medical Research Institute. He has published more than 130 papers in reputed journals with a current H index of 36.

His major research interest is in regulation of programmed cell death and survival signal pathways in melanoma cells.

Liane Deligdisch graduated Medical School in Bucharest, Romania. Following positions were: Gynecologist and General Physician in Romania until 1963, Pathologist at the Ichilov Hospital, Tel Aviv Medical School, Israel 1963 to 1975, Visiting Professor Magee Women Hospital in Pittsburgh, Pa.; 1975-6 Boston Free Hospital for Women, Harvard Medical School ; 1976 to present The Mount Sinai School of Medicine, full Professor of Pathology and Obstetrics-Gynecology and Attending since 1986. Founded the division of Gynecologic Pathology and directed the course of Gynecologic Pathology at the Medical School, Authored 143 peer reviewed articles , 7 textbooks on Gynecologic Pathology.

Gynecology, Obstetrics-Gynecology, Gynecologic Pathology

Dr. Alvaro Macieira-Coelho is a Research Director at the French National Institute of Health. He received an MD from the University of Lisbon, Portugal, and a PhD from the University of Uppsala Sweden. He made an internship at the University Hospital in Lisbon and was a research associate at the Wistar Institute in Philadelphia (USA) and at the Department of Cell Biology of the University of Uppsala (Sweden). He became Head of the Department of Cell Pathology at the Cancer Institute in Villejuif (France) and was a visiting Professor at the University of Linkoping (Sweden). He published 150 papers in professional Journals and 9 books on cancer and aging. He received the following awards: Fritz Verzar Prize (University of Vienna, Austria), “Seeds of Science”, Career Prize (Lisbon, Portugal), Dr. Honoris Causa (University of Linkoping, Sweden), Johananof International Visiting Professor (Institute Mario Negri, Milano, Italy).

Cancer Research, Cell Biology, Cancer and Aging, Molecular Biology

Dr. Sherry Bradford attended undergraduate school at SUNY at Buffalo and was awarded a full tuition scholarship to pursue her PhD graduate degree (Biochemistry) from the University of Buffalo/ Roswell Park Cancer Institute Division of SUNY at Buffalo School of Medical and Biomedical Sciences. During her clinical laboratory vocation, she was solicited by the Chief of Surgery at Millard Fillmore Hospital, Buffalo, NY, to direct the Surgical Research laboratory. There she successfully led the research on the use of human micro vascular umbilical cord endothelium for lining stents. It was while Sherry was at Millard Fillmore Hospital, that she was awarded the “1st Place - Award for Excellence in Research” from the American Federation for Clinical Research In 1997, Dr. Bradford was approached by the Department of Pharmacokinetics, at Millard Fillmore Hospital, to lead their newly formed Pharmacokinetics Oncology Department. As the Principal Investigator, she was charged with the responsibility to develop an in vitro chemo sensitivity test on tumor cells using the flow cytometer. In 2008, Dr Bradford and colleagues form AccuTheranostics and the idea on Oncology Personalized Medicine based on the specific patient’s own biochemical and genetic profile to administer Personalized treatment regimens.Currently, Dr. Bradford sits on the EDITORIAL BOARD of the International Journal of Medical and Health Sciences Research; commence on July 20 2014; and on the EDITORIAL BOARD of Insights in Cancer Research, and has authored and co-authored a number of scientific peer-reviewed manuscripts.She is also a member of many professional organizations including (but not limited to): International Metabolic Cancer Group, AACR, ASCO, and GLIFCA.

Human microvascular umbilical cord endothelium and in Pharmacokinetics Oncology

Eddy Shih-Hsin Yang, MD, PhD is an Associate Professor in the Department of Radiation Oncology at the University of Alabama at Birmingham (UAB), Endowed Chair of ROAR Southeast Cancer Foundation, Medical Director of the UAB Molecular Tumor Board, and member of the Clinical Trials Review Committee for the UAB Comprehensive Cancer Center. As a physician-scientist oncologist, he has particular interest in targeting of DNA repair pathways to enhance the therapeutic ratio and understanding the contributions of DNA damage and genome instability to carcinogenesis. He also strives to uncover potential biomarkers to inform and guide therapy in a more personalized medicine approach. He directs the UAB Nanostring Laboratory, which houses the nCounter platform by Nanostring Technologies. This technology allows for targeted analysis of molecular pathways at multiple levels, including DNA copy number variation, gene expression, microRNA, and protein analysis. His research in these pathways has led him to focus on breast, genitourinary, and head and neck cancers. His work has been supported by various funding sources, including the NIH Breast SPORE at UAB, the Susan G. Komen Foundation, the Department of Defense, the American Association for Cancer Research, and the Sidney Kimmel Foundation. He also has an excellent track record of productivity in DNA repair and cancer research. Ultimately, as a translational researcher, he hopes to implement findings from the laboratory into the clinic, whether from a therapeutic or prevention perspective.

particular interest in targeting of DNA repair pathways to enhance the therapeutic ratio and understanding the contributions of DNA damage and genome instability to carcinogenesis

Dr. Garbett received a B.Sc. and Ph.D. in Chemistry from the University of Kent at Canterbury. She completed postdoctoral fellowships at the University of Mississippi Medical Center, University of Mississippi and University of Alabama at Birmingham before joining the University of Louisville School of Medicine where she is currently an Assistant Professor of Medicine. Dr. Garbett’s research applies biophysical approaches to the study of biomolecules and their interactions, with emphasis on developing new technologies for medical diagnostics. She is a co-inventor of an emerging diagnostic tool utilizing differential scanning calorimetry for early detection, diagnosis and monitoring of patients.

Laboratory Operations, Disease Diagnostics

Xing Li has completed his PhD in Bioinformatics from The University of Michigan at Ann Arbor. He is an Assistant Professor in Division of Biomedical Statistics and Informatics, Department of Health Science Research at Mayo Clinic which has been recognized as the best hospital for 2014-2015 by US News & World Report. He has published more than 18 papers in reputed journals and has been serving as Peer Reviewers of over a dozen of journals, such as Genomics, BMC Bioinformatics, Stem Cell Research, PLOS ONE, Physiological Genomics, etc.

Stem Cell Research

Dr. Sabine Mai is a tenured Professor at The University of Manitoba (Winnipeg, Canada). She obtained her PhD at the University of Karlsruhe (Germany) and her postodctoral training at the Basel Instutite for Immunology (Basel, Switzerland).

Immunology, Genomics, Cancer

David I Smith, Ph.D. Is a Professor in the Department of Laboratory Medicine and Pathology at the Mayo Clinic. He is also the Chairman of the Technology Assessment Group for the Center for Individualized Medicine also of the Mayo Clinic. His own research focuses on the different roles that human papillomavirus plays in the development of different cancers. He is also using next generation sequencing to examine the genomic alterations that occur during the development of oropharyngeal squamous cell carcinoma, and then using this information to better inform clinical decisions.

His own research focuses on the different roles that human papillomavirus plays in the development of different cancers.